Carazolol

Carazolol
Clinical data
AHFS/Drugs.com	International Drug Names
ATCvet code	QC07AA90 (WHO) ;
Identifiers
	IUPAC name 1-(9H-carbazol-4-yloxy)-3-(propan-2-ylamino)propan-2-ol;
CAS Number	57775-29-8;
PubChem CID	71739;
IUPHAR/BPS	569;
ChemSpider	64783;
UNII	29PW75S82A;
ChEMBL	ChEMBL324665;
ECHA InfoCard	100.055.387
Chemical and physical data
Formula	C18H22N2O2
Molar mass	298.38 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES OC(CNC(C)C)COc3cccc2c3c1c(cccc1)[nH]2;

Carazolol is a high affinity antagonist/partial inverse agonist (also referred to as a beta blocker) of the β-adrenergic receptor.[1]

References

Innis RB, Corrēa FM, Synder SH (1979). "Carazolol, an extremely potent beta-adrenergic blocker: binding to beta-receptors in brain membranes". Life Sci. 24 (24): 2255–64. doi:10.1016/0024-3205(79)90102-4. PMID 41147.

Carazolol at the US National Library of Medicine Medical Subject Headings (MeSH)

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.